Page 8 - ஹாட்ஜ்கின்ஸ் லிம்போமா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Drugs Hold Promise to Treat Blood, Bone Marrow Cancers by Angela Mohan on  December 16, 2020 at 3:06 PM Blood Cancer Discovery. Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells. One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Jaroslaw Maciejewski, MD, PhD, a practicing hematologist and chair of the Cleveland Clinic Department of Translational Hematology & Oncology Research. In the new study, Dr. Maciejewski and his collaborator in the Department of Translational Hematology & Oncology Research, Babal Kant Jha, PhD, report a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations.

Babal kant jhaJaroslaw maciejewskiBiopsydrug toxicityleucopenia leukopeniainfantileHodgkins lymphomamultiple myelomadrugsLisa rayJames phillipsTransplantationrenal osteodystrophyCleveland clinic taussig cancer instituteLerner research instituteDepartment of translational hematology oncology researchCleveland clinicTaussig cancer instituteLerner researchBlood cancerCleveland clinic departmentTranslational hematology